Abstract 4507: Deletion of 9p21.3/p16/CDKN2A is associated with poorer survival in primary central nervous system (PCNSL) lymphoma independent of 6q22 effect. A study facilitated by the Surveillance, Epidemiology and End Results Tissue Repository Program (SEER TRP)
Year: 2012
Type: conference-abstract
Source: Cancer Research
Authors: Brian Patrick O'neill, Paul A. Decker, William R. Macon, Ellen D. McPhail, Mark Law, James R. Cerhan
Institution: Mayo Clinic
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2316502175